Literature DB >> 23589819

Quality improvement methods increase appropriate antibiotic prescribing for childhood pneumonia.

Lilliam Ambroggio1, Joanna Thomson, Eileen Murtagh Kurowski, Joshua Courter, Angela Statile, Camille Graham, Brieanne Sheehan, Srikant Iyer, Samir S Shah, Christine M White.   

Abstract

OBJECTIVE: In August 2011, the Pediatric Infectious Disease Society and Infectious Disease Society of America published an evidence-based guideline for the management of community-acquired pneumonia (CAP) in children ≥3 months. Our objective was to evaluate if quality improvement (QI) methods could improve appropriate antibiotic prescribing in a setting without a formal antimicrobial stewardship program.
METHODS: At a tertiary children's hospital, QI methods were used to rapidly implement the Pediatric Infectious Disease Society/Infectious Disease Society of America guideline recommendations for appropriate first-line antibiotic therapy in children with CAP. QI interventions focused on 4 key drivers and were tested separately in the emergency department and on the hospital medicine resident teams, using multiple plan-do-study-act cycles. Medical records of eligible patients were reviewed weekly to determine the success of prescribing recommended antibiotic therapy. The impact of these interventions on our outcome was tracked over time on run charts.
RESULTS: Appropriate first-line antibiotic prescribing for children admitted with the diagnosis of CAP increased in the emergency department from a median baseline of 0% to 100% and on the hospital medicine resident teams from 30% to 100% within 6 months of introducing the guidelines locally at Cincinnati Children's Hospital Medical Center and has been sustained for 3 months.
CONCLUSIONS: Our study demonstrates that QI methods can rapidly improve adherence to national guidelines even in settings without a formal antimicrobial stewardship program to encourage judicious antibiotic prescribing for CAP.

Entities:  

Keywords:  antibiotic use; pediatric; pneumonia

Mesh:

Substances:

Year:  2013        PMID: 23589819      PMCID: PMC3639461          DOI: 10.1542/peds.2012-2635

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  17 in total

1.  Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents.

Authors:  M R Cohen; J Senders; N M Davis
Journal:  Hosp Pharm       Date:  1994-04

2.  National hospitalization trends for pediatric pneumonia and associated complications.

Authors:  Grace E Lee; Scott A Lorch; Seth Sheffler-Collins; Matthew P Kronman; Samir S Shah
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

Review 3.  Reliability science and patient safety.

Authors:  Joseph W Luria; Stephen E Muething; Pamela J Schoettker; Uma R Kotagal
Journal:  Pediatr Clin North Am       Date:  2006-12       Impact factor: 3.278

4.  Community-acquired pneumonia: can it be defined with claims data?

Authors:  J Whittle; M J Fine; D Z Joyce; J R Lave; W W Young; L J Hough; W N Kapoor
Journal:  Am J Med Qual       Date:  1997       Impact factor: 1.852

5.  Accuracy of administrative data for identifying patients with pneumonia.

Authors:  Dominik Aronsky; Peter J Haug; Charles Lagor; Nathan C Dean
Journal:  Am J Med Qual       Date:  2005 Nov-Dec       Impact factor: 1.852

6.  Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services.

Authors:  C Feudtner; R M Hays; G Haynes; J R Geyer; J M Neff; T D Koepsell
Journal:  Pediatrics       Date:  2001-06       Impact factor: 7.124

7.  Influence of hospital guidelines on management of children hospitalized with pneumonia.

Authors:  Mark I Neuman; Matt Hall; Adam L Hersh; Thomas V Brogan; Kavita Parikh; Jason G Newland; Anne J Blaschke; Derek J Williams; Carlos G Grijalva; Amy Tyler; Samir S Shah
Journal:  Pediatrics       Date:  2012-10-22       Impact factor: 7.124

8.  Antimicrobial stewardship programs in pediatrics.

Authors:  Adam L Hersh; Susan E Beekmann; Philip M Polgreen; Theoklis E Zaoutis; Jason G Newland
Journal:  Infect Control Hosp Epidemiol       Date:  2009-12       Impact factor: 3.254

9.  Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies.

Authors:  R E Guevara; J C Butler; B J Marston; J F Plouffe; T M File; R F Breiman
Journal:  Am J Epidemiol       Date:  1999-02-01       Impact factor: 4.897

10.  International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia.

Authors:  Ewoudt M W van de Garde; Jan Jelrik Oosterheert; Marc Bonten; Robert C Kaplan; Hubert G M Leufkens
Journal:  J Clin Epidemiol       Date:  2007-02-23       Impact factor: 6.437

View more
  28 in total

1.  Diagnostic Testing and Antibiotic Use in Young Children With Community-Acquired Pneumonia in the United States, 2008-2015.

Authors:  Todd A Florin; Terri Byczkowski; Jeffrey S Gerber; Richard Ruddy; Nathan Kuppermann
Journal:  J Pediatric Infect Dis Soc       Date:  2020-04-30       Impact factor: 3.164

2.  Hospital outcomes associated with guideline-recommended antibiotic therapy for pediatric pneumonia.

Authors:  Joanna Thomson; Lilliam Ambroggio; Eileen Murtagh Kurowski; Angela Statile; Camille Graham; Joshua D Courter; Brieanne Sheehan; Srikant Iyer; Christine M White; Samir S Shah
Journal:  J Hosp Med       Date:  2014-09-27       Impact factor: 2.960

Review 3.  Antimicrobial Stewardship in the Emergency Department.

Authors:  Michael Pulia; Robert Redwood; Larissa May
Journal:  Emerg Med Clin North Am       Date:  2018-09-06       Impact factor: 2.264

4.  Impact of a National Guideline on Antibiotic Selection for Hospitalized Pneumonia.

Authors:  Derek J Williams; Matthew Hall; Jeffrey S Gerber; Mark I Neuman; Adam L Hersh; Thomas V Brogan; Kavita Parikh; Sanjay Mahant; Anne J Blaschke; Samir S Shah; Carlos G Grijalva
Journal:  Pediatrics       Date:  2017-03-08       Impact factor: 7.124

5.  Decreased Overall and Inappropriate Antibiotic Prescribing in a Veterans Affairs Hospital Emergency Department following a Peer Comparison-Based Stewardship Intervention.

Authors:  Deanna J Buehrle; Rameez H Phulpoto; Marilyn M Wagener; Cornelius J Clancy; Brooke K Decker
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

6.  Antibiotic Choice for Children Hospitalized With Pneumonia and Adherence to National Guidelines.

Authors:  Derek J Williams; Kathryn M Edwards; Wesley H Self; Yuwei Zhu; Krow Ampofo; Andrew T Pavia; Adam L Hersh; Sandra R Arnold; Jonathan A McCullers; Lauri A Hicks; Anna M Bramley; Seema Jain; Carlos G Grijalva
Journal:  Pediatrics       Date:  2015-07       Impact factor: 7.124

7.  Oral antibiotics at discharge for children with acute osteomyelitis: a rapid cycle improvement project.

Authors:  Patrick W Brady; William B Brinkman; Jeffrey M Simmons; Connie Yau; Christine M White; Eric S Kirkendall; Joshua K Schaffzin; Patrick H Conway; Michael T Vossmeyer
Journal:  BMJ Qual Saf       Date:  2013-12-17       Impact factor: 7.035

8.  Variation in resource utilization for the management of uncomplicated community-acquired pneumonia across community and children's hospitals.

Authors:  JoAnna K Leyenaar; Tara Lagu; Meng-Shiou Shieh; Penelope S Pekow; Peter K Lindenauer
Journal:  J Pediatr       Date:  2014-06-25       Impact factor: 4.406

Review 9.  Aggregate and hospital-level impact of national guidelines on diagnostic resource utilization for children with pneumonia at children's hospitals.

Authors:  Kavita Parikh; Matt Hall; Anne J Blaschke; Carlos G Grijalva; Thomas V Brogan; Mark I Neuman; Derek J Williams; Jeffrey S Gerber; Adam L Hersh; Samir S Shah
Journal:  J Hosp Med       Date:  2016-01-13       Impact factor: 2.960

10.  Standardized Clinical Pathways for Hospitalized Children and Outcomes.

Authors:  K Casey Lion; Davene R Wright; Suzanne Spencer; Chuan Zhou; Mark Del Beccaro; Rita Mangione-Smith
Journal:  Pediatrics       Date:  2016-03-21       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.